Norvaline Derivative and Method for Preparation Thereof
AssigneeMitsubishi Tanabe Pharma Corporation
InventorsNaoyuki Harada, Masataka Hikota
Life of this patent
Estimating the term…
Loading patent…
AssigneeMitsubishi Tanabe Pharma Corporation
InventorsNaoyuki Harada, Masataka Hikota
Estimating the term…
Norvaline derivative of the formula [I] or pharmaceutically acceptable salt thereof, method for preparing the same, pharmaceutical composition containing the same, and use of said compound for inhibiting transporting activity of glycine transporter type 2 (GlyT2). [wherein X is —CH2—, —O—, —S— or single bond; Ar is optionally substituted aryl or lower cycloalkyl; n is 0 to 2; R1 and R2 are (i) each is hydrogen or lower alkyl; (ii) R1 and R2 are combined to form lower alkylene; or (iii) R1 is hydrogen or lower alkyl and R2 is combined with R4 or R6 to form lower alkylene; R3 and R4 are (i) each is hydrogen or lower alkyl; (ii) R3 and R4 are combined to form lower alkylene; or (iii) R3 is hydrogen or lower alkyl and R4 is combined with R2 or R6 to form lower alkylene; R is or —OR7; R5 and R6 are (i) each is optionally substituted lower alkyl, or hydrogen; (ii) R5 and R6 are combined to form aliphatic 5- to 6-membered heterocyclic group; or (iii) R5 is optionally substituted lower alkyl or hydrogen and R6 is combined with R2 or R4 to form lower alkylene; R7 is lower alkyl.
A norvaline derivative of the formula [I]:
A free form of each compound as disclosed in Examples, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.